Novamind Inc.
Share capitalization Issued & outstanding: 40,200,767 Reserved for issuance: 7,887,792
Former LifeLabs COO Joins Novamind Leadership Team
January 19, 2021
Novamind Expands Psychedelic Medicine Access in Utah
January 13, 2021
Novamind Appoints Chuck Rifici to its Board of Directors
January 08, 2021
Novamind to Commence Trading (CSE:NM) on January 5, 2021
January 04, 2021
Filing Statement
December 31, 2020
View PDF
Material Change Report
November 12, 2020
July 3, 2020
To view Novamind's full financial disclosures, please visit SEDAR
Transfer agent
Marrelli Trust Company Limited
Legal Counsel
McMillan LLP
Auditor
DMCL LLP